Overview:
Harbour Antibodies now offers a single-target Evaluation Program through the services performed at designated Discovery Partners. This Evaluation Program facilitates easy access to the H2L2 platform with low, pre-negotiated and success-based fees for a single target.
Terms:
Single Target
- Upfront Evaluation Fee:
½ of Evaluation Fee - Evaluation Completion Fee:
½ of Evaluation Fee Upon Completion of Criteria - Review of Evaluation Data
- Obtain Commercial License with Harbour
Success Criteria:
The success criteria for the Evaluation Program will be determined between you and the Discovery Partner for your target.
Evaluation Program:
Test Harbour’s H2L2 fully human transgenic mouse platform for a single target.
Commercial License:
Upon Evaluation of the results with your Discovery Partner, enter into a single program Commercial License with Harbour to obtain commercial rights to the successful target.
Discovery Partners:
- AbCellera Biologics
- ImmunoPrecise Antibodies
- Lakepharma
Contact Information:
Timothy Miller
E: Timothy.Miller@HarbourBioMed.com
T: (857) 214-0976
www.harbourbiomed.com